Clinical Trial Update: Donor Versus Autologous Fecal Microbiota Transplantation for Irritable Bowel Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial update for donor versus autologous fecal microbiota transplantation in irritable bowel syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Fecal microbiota transplantation (FMT)

Snippet

Sponsor: University Hospital of North Norway | Conditions: Irritable Bowel Syndrome | Phase 3 | Status: ACTIVE_NOT_RECRUITING